“Treat-to-Target Outcomes and Measures of Treatment Success in Three Phase 3 Trials of Tapinarof Cream 1% Once Daily for Mild to Severe Plaque Psoriasis” (2023) SKIN The Journal of Cutaneous Medicine, 7(2), p. s124. doi:10.25251/skin.7.supp.124.